Twinbeech Capital LP Guardant Health, Inc. Transaction History

Twinbeech Capital LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$16.07 - $31.84 $815,391 - $1.62 Million	50,740 New	50,740 $1.47 Million
Q4 2023 Feb 14, 2024	BUY	$21.58 - $29.5 $642,544 - $878,362	29,775 New	29,775 $805,000
Q1 2023 May 15, 2023	SELL	$22.92 - $33.76 $473,939 - $698,089	-20,678 Reduced 6.69%	288,256 $6.76 Million
Q4 2022 Feb 14, 2023	BUY	$25.44 - $59.78 $7.86 Million - $18.5 Million	308,934 New	308,934 $8.4 Million
Q2 2022 Aug 15, 2022	SELL	$28.82 - $77.35 $823,906 - $2.21 Million	-28,588 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$48.25 - $100.49 $1.38 Million - $2.87 Million	28,588 New	28,588 $1.89 Million

330

127M

843K

2.37M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $4.54B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.